FTHFX
Price
$58.72
Change
+$0.60 (+1.03%)
Updated
Sep 11 closing price
Net Assets
12.15B
NSCKX
Price
$28.98
Change
-$0.10 (-0.34%)
Updated
Sep 11 closing price
Net Assets
377.05M
Interact to see
Advertisement

FTHFX vs NSCKX

FTHFX vs NSCKX Comparison Chart in %
View a ticker or compare two or three
VS
FTHFX vs. NSCKX commentary
Sep 13, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FTHFX is a Buy and NSCKX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FTHFX has more cash in the bank: 12.1B vs. NSCKX (377M). NSCKX pays higher dividends than FTHFX: NSCKX (0.61) vs FTHFX (0.56). FTHFX was incepted earlier than NSCKX: FTHFX (15 years) vs NSCKX (6 years). FTHFX (0.64) is less costly to investors than NSCKX (0.48). FTHFX is a more actively managed with annual turnover of: 28.00 vs. NSCKX (18.92). NSCKX has a lower initial minimum investment than FTHFX: NSCKX (2500) vs FTHFX (1000000). FTHFX annual gain was more profitable for investors over the last year : 15.30 vs. NSCKX (5.36). FTHFX return over 5 years is better than : 60.92 vs. NSCKX (-8.80).
FTHFXNSCKXFTHFX / NSCKX
Total Expense Ratio0.640.41156%
Annual Report Gross Expense Ratio0.640.48133%
Fund Existence15 years6 years-
Gain YTD14.83919.22377%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets12.1B377M3,210%
Annual Yield % from dividends0.560.6193%
Returns for 1 year15.305.36286%
Returns for 3 years58.6814.34409%
Returns for 5 years60.92-8.80-692%
Returns for 10 years237.29N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HGHIX45.99N/A
N/A
Hartford Healthcare I
PLBEX35.20N/A
N/A
Plumb Equity Investor
GAOZX21.91N/A
N/A
JPMorgan Global Allocation R6
FIAOX33.64N/A
N/A
Fidelity Advisor® Equity Dividend Inc A
MYIIX11.94-0.03
-0.25%
NYLIM WMC International Research Eq Cl I